title: [Pregnancy and perinatality: biological follow-up].
abstract: Blood and urinary tests which are necessary for pregnancy diagnosis and follow-up, for newborn and mother medical supervision, during the month following birthday, are today described in reglementary texts, laws, and recommendations such as advised medical references (RMO). These documents specify the nature of obligatory tests, the checking rhythm and the list of useless tests. hCG research remains necessary for pregnancy diagnosis, but hCG dosage is essential only in case of programmed medical assistance or pathological pregnancy (extrauterine pregnancy, hydatiform mole, choriocarcinoma). The obligatory follow-up of a pregnant woman includes determination of blood groups, research of infectious agents responsible for diseases (toxoplasmosis, rubeola, hepatitis B, syphilis), proteinuria and glycosuria research and blood count according to a given calendar. When the mother's condition is bad and reminiscent of a pathological pregnancy, when a genetic risk exists for the fetus or when fetal growth is abnormal as indicated by echographic control (intra-uterine growth retardation), laboratory tests are used to follow the maternal pathological course (arterial hypertension, diabetes mellitus, anemia, bacterial, viral or parasitic disease), to verify the existence of a genetic disease, to know about the fetal functional state (by amniocentesis or cordocentesis), to identify an erythrocyte fetomaternal incompatibility. Since last trimester pregnancy accidents are able to endanger mother's and fetus lives, the feto-maternal follow-up must be adjusted to pathological diagnosis types and requires a particular supervision of the delivery. Finally mother and child must undergo a post-natal follow-up during the four weeks after birthday (perinatality control).
authors.affiliation: Laboratoire de Chimie biologique, Maternité régionale A.-Pinard, Nancy.
authors.forename: Y
authors.initials: Y
authors.lastname: Badonnel
authors.forename: M
authors.initials: M
authors.lastname: Berland
authors.forename: I
authors.initials: I
authors.lastname: Lacroix
authors.forename: M C
authors.initials: MC
authors.lastname: Patricot
authors.forename: A
authors.initials: A
authors.lastname: Revol
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D010500:Perinatology / Q000331:legislation & jurisprudence*; D011247:Pregnancy / Q000378:metabolism*; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000378:metabolism; D011256:Pregnancy Outcome; D011258:Pregnancy Tests; D011296:Prenatal Diagnosis